Coeptis Therapeutics, Inc. (COEP)
USD 9.75
(2.85%)
USD 9.75
(2.85%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.07 Million USD | 1.96% |
| 2022 | 7.91 Million USD | 17.0% |
| 2021 | 6.76 Million USD | 2151.56% |
| 2020 | 300.48 Thousand USD | 75.16% |
| 2019 | 171.54 Thousand USD | 114.43% |
| 2018 | 80 Thousand USD | 0.0% |
| 2005 | 153.55 Thousand USD | 227.27% |
| 2004 | 46.92 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 9.39 Million USD | 16.39% |
| 2024 Q2 | 11.74 Million USD | 25.06% |
| 2023 FY | 8.07 Million USD | 1.96% |
| 2023 Q3 | 7.17 Million USD | 0.21% |
| 2023 Q4 | 8.07 Million USD | 12.56% |
| 2023 Q2 | 7.15 Million USD | 20.42% |
| 2023 Q1 | 5.94 Million USD | -24.93% |
| 2022 Q3 | 11.26 Million USD | 72.67% |
| 2022 FY | 7.91 Million USD | 17.0% |
| 2022 Q4 | 7.91 Million USD | -29.73% |
| 2022 Q1 | 6.74 Million USD | -0.25% |
| 2022 Q2 | 6.52 Million USD | -3.34% |
| 2021 Q1 | 76.59 Million USD | 1551082.04% |
| 2021 FY | 6.76 Million USD | 2151.56% |
| 2021 Q4 | 6.76 Million USD | -91.14% |
| 2021 Q3 | 76.36 Million USD | -0.11% |
| 2021 Q2 | 76.44 Million USD | -0.2% |
| 2020 FY | 300.48 Thousand USD | 75.16% |
| 2020 Q4 | 4938.00 USD | 209.98% |
| 2020 Q3 | 1593.00 USD | 0.0% |
| 2019 FY | 171.54 Thousand USD | 114.43% |
| 2018 FY | 80 Thousand USD | 0.0% |
| 2005 FY | 153.55 Thousand USD | 227.27% |
| 2005 Q4 | 153.55 Thousand USD | 187.73% |
| 2005 Q2 | 53.36 Thousand USD | 15104.84% |
| 2005 Q3 | 53.36 Thousand USD | 0.0% |
| 2005 Q1 | 351.00 USD | -99.25% |
| 2004 Q3 | 46.92 Thousand USD | 0.0% |
| 2004 Q4 | 46.92 Thousand USD | 0.0% |
| 2004 FY | 46.92 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -349297.792% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -312.171% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 23.526% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -1361.836% |
| Rebus Holdings, Inc. | 5000.00 USD | -161321.78% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 93.802% |
| Qrons Inc. | 420.00 USD | -1921587.857% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -947.317% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 71.117% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -1579.528% |
| Skye Bioscience, Inc. | 11.94 Million USD | 32.405% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 79.223% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -11.792% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -10470.617% |
| SQZ Biotechnologies Company | 107.18 Million USD | 92.47% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -463.611% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -11053.305% |
| Mesoblast Limited | 667.9 Million USD | 98.792% |
| Marizyme, Inc. | 22.01 Million USD | 63.338% |
| Genus plc | 1.02 Billion USD | 99.216% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -494.182% |
| Pharming Group N.V. | 462.85 Million USD | 98.256% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -143.618% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -1517.326% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -1187.255% |
| ContraFect Corporation | 20.67 Million USD | 60.97% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -1967.57% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -2011.872% |
| IMV Inc. | 31.33 Million USD | 74.242% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -94.671% |
| MultiCell Technologies, Inc. | 126.22 USD | -6394361.258% |
| ONE Bio Corp. | 70.08 Million USD | 88.484% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -758.911% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 93.719% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -1769.545% |
| Q BioMed Inc. | 3.51 Million USD | -129.585% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 77.057% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -2989.093% |
| Biomind Labs Inc. | 73.81 Thousand USD | -10833.62% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 98.192% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -457.071% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 73.11% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -193.886% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -1074.0% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -210.045% |
| GB Sciences, Inc. | 103.44 Thousand USD | -7702.526% |
| Alpha Cognition Inc. | 2.45 Million USD | -229.141% |
| HST Global, Inc. | 1526.00 USD | -528804.915% |
| CSL Limited | 38.02 Billion USD | 99.979% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -716.939% |
| Halberd Corporation | 10.13 Thousand USD | -79567.249% |
| Enzolytics Inc. | 361.7 Million USD | 97.769% |
| Agentix Corp. | 261.39 Thousand USD | -2987.734% |
| Resverlogix Corp. | 8.11 Million USD | 0.541% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -329.798% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.822% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 83.08% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -1161.786% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -35329.037% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 9.812% |
| AVAX Technologies, Inc. | 7.37 Million USD | -9.406% |
| Zenith Capital Corp. | 7410.00 USD | -108821.579% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.762% |
| Ember Therapeutics, Inc. | 184.00 USD | -4386361.413% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -2408.06% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -2988.065% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -769.766% |
| Kadimastem Ltd | 2.3 Million USD | -250.296% |
| Helix BioMedix, Inc. | 3.02 Million USD | -166.805% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 84.685% |
| BioStem Technologies, Inc. | 14.56 Million USD | 44.568% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -14036.492% |
| LadRx Corporation | 2.3 Million USD | -249.718% |
| Cell Source, Inc. | 195.17 Thousand USD | -4035.394% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -2182.438% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -2182.438% |
| NovAccess Global Inc. | 62.24 Thousand USD | -12866.021% |
| Affymax, Inc. | 7.44 Million USD | -8.439% |
| Itoco Inc. | 1.4 Million USD | -476.477% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -8337.531% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -7514.235% |
| Mobile Lads Corp. | 52.00 USD | -15521225.0% |
| CytoDyn Inc. | 11.13 Million USD | 27.523% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -5545.224% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -45040.319% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -1993.825% |
| SYBLEU INC | 330.46 Thousand USD | -2342.321% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -1871.337% |
| International Stem Cell Corporation | 5.39 Million USD | -49.742% |
| Bioxytran, Inc. | 137.63 Thousand USD | -5763.998% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 46.199% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 51.317% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -10116.568% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -833.422% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -7.371% |
| Neutra Corp. | 2851.00 USD | -282996.773% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 75.094% |
| PureTech Health plc | 693.97 Million USD | 98.837% |
| IXICO plc | 15.84 Million USD | 49.059% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 2.547% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 92.189% |
| CSL Limited | 38.02 Billion USD | 99.979% |
| Cellectis S.A. | 333.99 Million USD | 97.583% |